January 19, 2025 - 22:11

Investors brace for a volatile ride as President-elect Donald Trump’s second term gets underway on Monday, bringing the promise of significant policy shifts. Market analysts are closely examining which sectors may emerge as winners and losers under the incoming administration.
Historically, Trump's policies have had a profound impact on various industries, with energy, defense, and financial sectors often benefiting from his administration's initiatives. The anticipated focus on deregulation and tax cuts is expected to give a boost to these areas, attracting investor interest. Conversely, sectors such as technology and healthcare may face headwinds due to potential regulatory changes and shifts in trade policies.
As the new term unfolds, investors are advised to stay alert and agile, ready to adapt their strategies in response to the unfolding political landscape. The uncertainty surrounding Trump's agenda, combined with the ongoing economic recovery, suggests that volatility will be a defining feature of the markets in the coming months.
May 14, 2026 - 12:10
ASX Penny Stocks To Watch: Bell Financial Group And Two OthersThe Australian share market has been under pressure lately, weighed down by the latest federal budget and ongoing global economic headwinds. Yet even in a down market, some investors are looking...
May 13, 2026 - 20:03
Should you buy Series I bonds as inflation heats up again?Series I bonds are once again drawing interest from savers looking for a secure way to protect their cash from rising prices. With inflation showing signs of heating up, these government-backed...
May 13, 2026 - 03:39
Nyxoah Reports First Quarter 2026 Financial and Operating ResultsNyxoah SA, a medical technology company developing treatments for Obstructive Sleep Apnea, reported its financial and operating results for the first quarter of 2026 on May 12. The company pointed...
May 12, 2026 - 00:33
Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing CostsGilead Sciences, Inc. (GILD) recently saw its fiscal 2026 outlook take a significant hit, with analysts pointing to a massive $11.5 billion charge tied to in-process research and development (IPR&D...